![Seppo Ylä-Herttuala](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Seppo Ylä-Herttuala
Corporate Officer/Principal at University of Kuopio
Seppo Ylä-Herttuala active positions
Companies | Position | Start | End |
---|---|---|---|
University of Kuopio | Corporate Officer/Principal | 23/11/2010 | - |
Career history of Seppo Ylä-Herttuala
Former positions of Seppo Ylä-Herttuala
Companies | Position | Start | End |
---|---|---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Director/Board Member | 10/09/2009 | 14/03/2013 |
Founder | 10/09/2009 | 14/03/2013 | |
Corporate Officer/Principal | 10/09/2009 | 14/03/2013 | |
FinVector Oy
![]() FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Founder | 31/12/1992 | - |
Training of Seppo Ylä-Herttuala
University of Tampere | Doctorate Degree |
Statistics
International
Finland | 4 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 2 |
Founder | 2 |
Director/Board Member | 1 |
Sectoral
Consumer Services | 3 |
Commercial Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Ark Therapeutics Group Plc
![]() Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom. | Commercial Services |
FinVector Oy
![]() FinVector Oy Pharmaceuticals: MajorHealth Technology Part of Ferring Ventures, FinVector Oy is a Finnish biopharmaceutical company that specializes in manufacturing viral-based gene therapy products. The company is based in Kuopio, Finland, and has extensive experience in cgmp manufacturing. FinVector employs hundreds of highly qualified professionals from over 40 different countries and works on cutting-edge biopharmaceuticals. It has invested in building state-of-the-art gmp facilities for viral vector platforms. The company was founded in 1993 by Seppo Ylä-Herttuala, and the CEO is Giuseppe Carloni. | Health Technology |
- Stock Market
- Insiders
- Seppo Ylä-Herttuala
- Experience